Nebojsa Skuljec has held various positions in MSD Healthcare across the Balkans before his promotion to country lead for Serbia and Balkans emerging markets 14 months ago. In this interview Skuljec tells the story of MSD’s journey from humble origins to one of the big pharma players in Serbia, growth drivers in a turbulent market and the importance of Corporate Social Responsibility (CSR) both personally and on a professional level, in an increasingly self-serving world.
Would you be able to take us though your journey from MSD’s establishment in Serbia to being one of the country’s top innovators?
"We at MSD believe that the government may consider recognizing the need to invest more in innovative medicines."
